Find your next M&A target
Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.
Project details
Japanese pharmaceutical company seeks 100% share sale for USD 44.5 million.
| Project region | Japan |
|---|---|
| Industry | Pharmeceuticals & Chemical |
| Total value of the target | N/A |
| Expected target net rate of return after deducting all taxes and fees | N/A |
| Validity period of pending order | 365 |
CONTACT ADVISOR
Simon Laube
Assistant Manager, International Business Advisory
| Project highlights | injection products manufacturer and medical supplier - RTU - USD 44.5 million turnover in 2020 |
|---|---|
| Project description |
The Japanese company manufactures and sells pharmaceutical products mainly for injection and also is entrusted with manufacturing medical supplies. For many years, the company has provided glass ampoule injections for the medical industry in Japan, and at the same time, it has fully met the ready-to-use ("RTU") medical needs by producing unique soft package injections. The company supplies high-quality products to all parts of Japan through its own sales network and other new medicine and generic medicine sales enterprises. In 2020, the company's turnover is about USD 44.5 million (JPY 6 billion). It has 200 employees and more than 32,000 medical institution customers. At present, more than 30 enterprises have entrusted manufacturing business with the company. It realizes the plastic soft package drip product of small volume infusion (50-300ml). The company seeks 100% share sale for USD 44.5 million (JPY 6 billion). |
Enquire for more information about our services, and how we can help solve challenges for your organization
Contact Us